Development of a complex intervention for the treatment of gout in primary care

ISRCTN ISRCTN26368503
DOI https://doi.org/10.1186/ISRCTN26368503
Secondary identifying numbers 7525
Submission date
23/04/2010
Registration date
23/04/2010
Last edited
22/07/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Ms Helen Richardson
Scientific

Nottingham City Hospital
Academic Rheumatology
Clinical Sciences Building
Nottingham
NG5 1PB
United Kingdom

Study information

Study designNon-randomised observational treatment and qualitative study
Primary study designObservational
Secondary study designCohort study
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleDevelopment of a complex intervention for the treatment of gout in primary care: a non-randomised observational treatment and qualitative study
Study acronymDCI-Gout
Study objectivesPhase 1 contains the development and feasibility work that is required prior to the community based RCT:
1. To develop a practical and acceptable nurse-led complex intervention for gout
2. To explore the potential barriers to such an intervention and adapt the intervention for optimial effectiveness
3. Address the following question: given optimal circumstances (i.e., a dedicated expert gout clinic), can application of the key component of the current management guidelines achieve the therapeutic target (serum uric acid [SUA] less than 360 umol/L)?

To identify possible barriers to the delivery of, and adherence to the intervention, indepth interviews will be arranged with 12 participants with gout, GPs and practices nurses. In addition, 6 GPs and 6 practice nurses will also be invited to participate in a focus group.
Ethics approval(s)Nottingham Research Ethics Committee 2 approved on the 12th October 2009 (ref: 09/H0408/94)
Health condition(s) or problem(s) studiedTopic: Primary Care Research Network for England, Musculoskeletal; Subtopic: Not Assigned, Musculoskeletal (all Subtopics); Disease: Musculoskeletal, All Diseases
InterventionInterventions will be based on the key elements of high quality gout management included in the EULAR and BSR guidelines. Following clinical assessment, study participants will be advised with respect to lifestyle modifications and, if relevant, will be prescribed licensed serum uric acid lowering medication (e.g., Allopurinol). The medication, dose and frequency will be dependent up on individual requirements. The number of attendances will also be based on the individual's clinical requirements.
Intervention typeOther
Primary outcome measureSerum uric acid reduced to below 360 umol/L at 12 months
Secondary outcome measuresClinical outcomes such as frequency of acute attacks and number and size of tophi will be recorded
Overall study start date01/02/2010
Completion date31/05/2010

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participantsPlanned Sample Size: 100; UK Sample Size: 100
Key inclusion criteria1. Confirmed diagnosis of gout
2. SUA greater than 360 umol
3. Male and female, lower age limit of 30 years
Key exclusion criteriaGout cases with a SUA less than 360 umol/L (GPs asked not to contact patients with terminal illness or severe mental illness and those unable to give informed consent)
Date of first enrolment01/02/2010
Date of final enrolment31/05/2010

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Nottingham City Hospital
Nottingham
NG5 1PB
United Kingdom

Sponsor information

University of Nottingham (UK)
University/education

University Park
Nottingham
NG7 2RD
England
United Kingdom

Website http://www.nottingham.ac.uk/
ROR logo "ROR" https://ror.org/01ee9ar58

Funders

Funder type

Charity

Arthritis Research Campaign (ARC) (UK) (ref: 18827)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/06/2013 Yes No